XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 54.8 $ 224.0
Restricted cash 65.1 65.4
Accounts receivable 680.3 572.8
Prepaid expenses and other current assets 121.2 86.4
Total current assets 921.4 948.6
Property and equipment, net 2,601.6 2,206.6
Operating lease right-of-use assets 242.0 245.7
Goodwill 2,427.9 2,318.7
Intangible assets, net 417.5 431.3
Other long-term assets 254.5 295.0
Total assets [1] 6,864.9 6,445.9
Current liabilities:    
Current portion of long-term debt 42.8 38.3
Current operating lease liabilities 38.4 44.8
Accounts payable 137.6 115.0
Accrued payroll 265.8 253.8
Accrued interest payable 44.5 47.1
Other current liabilities 219.7 218.3
Total current liabilities 748.8 717.3
Long-term debt, net of current portion 3,243.9 3,250.6
Long-term operating lease liabilities 213.1 209.6
Self-insured risks 123.8 121.2
Deferred income tax liabilities 86.7 51.8
Other long-term liabilities 49.4 93.8
Total liabilities 4,465.7 4,444.3
Commitments and contingencies
Redeemable noncontrolling interests 42.2 31.6
Encompass Health shareholders’ equity:    
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 114,211,057 in 2021; 113,835,708 in 2020 1.1 1.1
Capital in excess of par value 2,289.6 2,326.6
Accumulated income (deficit) 141.8 (242.3)
Treasury stock, at cost (14,719,662 shares in 2021 and 14,428,235 shares in 2020) (521.2) (497.4)
Total Encompass Health shareholders’ equity 1,911.3 1,588.0
Noncontrolling interests 445.7 382.0
Total shareholders’ equity 2,357.0 1,970.0
Total liabilities and equity [1] $ 6,864.9 $ 6,445.9
[1] Our consolidated assets as of December 31, 2021 and December 31, 2020 include total assets of variable interest entities of $226.2 million and $221.2 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2021 and December 31, 2020 include total liabilities of the variable interest entities of $38.2 million and $46.8 million, respectively. See Note 3, Variable Interest Entities.